As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at one noteworthy recent insider buy.
On Friday, Director Dayton Misfeldt purchased $800,000 worth of Sunesis Pharmaceuticals (NASDAQ:SNSS), purchasing 400,000 shares at a cost of $2.00 a piece. Sunesis Pharmaceuticals is trading up about 0.5% on the day Tuesday. So far Misfeldt is in the green, up about 14.5% on their buy based on today's trading high of $2.29.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.